← back to search

Luís Zapata

Institute of Cancer Research · GB
Area of research
Electrical and Electronic Engineering · Atomic and Molecular Physics, and Optics
Research interest
Research interests include Solid State Laser Technologies, Laser Design and Applications, Laser-Matter Interactions and Applications, and Cancer Genomics and Diagnostics.
h-index
35
citations
4,588
works
234
NIH funding
primary concept
Physics
email

Recent publications

Distinct molecular profiles associated with early vs late genome instability in cancer
Scientific Reports 2026cited by 0position: middledoi
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma
Nature Cancer 2025cited by 12position: middledoi
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma.
2025cited by 8position: contributordoi
The genomic landscape of 2,023 colorectal cancers
Nature 2024cited by 147position: middledoi
The genomic landscape of 2,023 colorectal cancers.
2024cited by 114position: contributordoi
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.
2024cited by 21position: contributordoi
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Nature Genetics 2024cited by 17position: middledoi
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer.
2024cited by 13position: contributordoi
Immune evasion impacts the landscape of driver genes during cancer evolution.
2024cited by 5position: contributordoi
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer
2024cited by 5position: contributordoi
The temporal evolution of cancer hallmarks
2024cited by 0position: contributordoi
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors.
2023cited by 55position: contributordoi
Phenotypic plasticity and genetic control in colorectal cancer evolution.
2022cited by 136position: contributordoi
The co-evolution of the genome and epigenome in colorectal cancer.
2022cited by 99position: contributordoi
Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor
National Science Review 2022cited by 31position: middledoi
Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor.
2022cited by 12position: contributordoi
Immune evasion impacts the selective landscape of driver genes during tumorigenesis
2022cited by 0position: contributordoi
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
2020cited by 195position: contributordoi
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes
The Oncologist 2020cited by 110position: middledoi
Subclonal reconstruction of tumors by using machine learning and population genetics.
2020cited by 99position: contributordoi
Evolutionary dynamics of neoantigens in growing tumors.
2020cited by 96position: contributordoi
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
2020cited by 90position: contributordoi
Measuring the distribution of fitness effects in somatic evolution by combining clonal dynamics with dN/dS ratios.
2020cited by 40position: contributordoi
Nuclear gene proximity and protein interactions shape transcript covariations in mammalian single cells.
2020cited by 30position: contributordoi
The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues.
2020cited by 26position: contributordoi
Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking.
2020cited by 26position: contributordoi
<i>dN/dS</i> dynamics quantify tumour immunogenicity and predict response to immunotherapy
2020cited by 0position: contributordoi
Allele balance bias identifies systematic genotyping errors and false disease associations.
2019cited by 33position: contributordoi
Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.
2019cited by 15position: contributordoi
Model-based tumor subclonal reconstruction
2019cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Andrea Sottoriva · Institute of Cancer Research15 papers (2019–2024)Trevor A Graham · Genomics (United Kingdom)10 papers (2019–2025) · 8 papers (2019–2024)Timon Heide · Institute of Cancer Research7 papers (2019–2024)Benjamin Werner · Genomics England7 papers (2019–2024)George D. Cresswell · Cancer Research Institute of the Slovak Academy of Sciences7 papers (2019–2024)Franz X. Kärtner · Universität Hamburg6 papers (2013–2018)Marc J. Williams · Northumbria University6 papers (2019–2023)Eszter Lakatos · Babeș-Bolyai University6 papers (2020–2025)Ann-Marie Baker · University College London5 papers (2022–2025)Chris P Barnes · University of Michigan5 papers (2019–2022)Marnix Jansen · Octapharma (Austria)5 papers (2022–2025)Giulio Caravagna · Cancer Research UK5 papers (2019–2025)Kyung-Han Hong · Massachusetts Institute of Technology5 papers (2013–2015)Manuel Rodriguez-Justo · Hospital General de Granollers4 papers (2022–2024)Jacob Househam · Genomics (United Kingdom)4 papers (2020–2024)John Bridgewater · National Cancer Center Hospital East3 papers (2022–2024)Maximilian Mossner · Institute of Cancer Research3 papers (2022–2024)Inmaculada Spiteri · Institute of Cancer Research3 papers (2022–2024)Luca Magnani · Imperial College London3 papers (2020–2022)